Pharmaceutical Technology, June 2022

IVPT Data Analysis with FDA Statistical Approach to Assess Bioequivalence

June 03, 2022

Peer-Reviewed Research

46

6

This article describes the in-vitro permeation test study data processing procedures and FDA statistical mathematics of evaluating a generic topical drug product, acyclovir cream, against its reference product.

Considerations for Cleaning Lipid Nanoparticles

June 02, 2022

Manufacturing

46

6

This article explores the concerns with cleaning pharmaceutical products utilizing LNP delivery vehicles and provides a general cleaning recommendation based on laboratory and field testing.

Enhanced Role of EMA in EU Crisis Response

June 02, 2022

Regulatory Watch

46

6

EMA has been assigned a formal role in preparing for and managing future public health crises within the EU through the formalization of ad-hoc structures and processes that were employed during the COVID-19 pandemic.

An Unusual Threat: Pharma is Already Tackling the Monkeypox Outbreak

June 02, 2022

From The Editor

46

6

Cases of monkeypox are rising around the world, but it is unlikely the virus will become a pandemic problem.

The Next Pandemic

June 02, 2022

From The Editor

46

6

Lions and tigers and monkeypox, oh my!

Productive Client-CDMO Relationships

June 02, 2022

Ask the Expert

46

6

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the basics for maintaining an acceptable working relationship between a client and their CDMO.

Is AI a Panacea for Pharma’s Productivity Gap?

June 02, 2022

From the CEO

46

6

AI could provide solutions to critical manufacturing inefficiencies.